期刊
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
卷 18, 期 3, 页码 396-413出版社
CANADIAN SOC PHARMACEUTICAL SCIENCES
DOI: 10.18433/J36W3X
关键词
-
A new platform for drug, gene and peptide-protein delivery is emerging, under the common name of extracellular vesicles. Extracellular vesicles (EVs) are 30-1000 nm-sized cell-derived, liposome-like vesicles. Current research on EVs as nano-delivery systems for small-molecule drugs and genetic material, reveal that these tiny, biologically-derived vesicles carry a great potential to boost the efficacy of many therapeutic protocols. Several features of EVs; from efficacy to safety, from passive to active targeting ability, the opportunity to be biologically or chemically labelled, and most importantly, their eobiotic origin make them promising candidate for development of the next generation personalized nanomedicines. The aim of this article is to provide a view on the current research in which EVs are used as drug/genetic material delivery systems. Their application areas, drug loading and targeting strategies, and biodistribution properties are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据